The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Lithium Carbonate and Isocarboxazid—An Effective Drug Approach in Severe Depressions

Published Online:https://doi.org/10.1176/ajp.127.10.1400

The author presents three case reports that emphasize the difficulties in finding an effective antidepressant drug program for regularly recurring depressions. All three patients responded well to the combination of lithium carbonate and isocarboxazid. The author concludes that lithium and at least one monoamine oxidase inhibitor may act synergistically in relieving certain severe depressions in manic-depressive illness.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.